A hormone such as prolactin, whose normal action is to promote cell proliferation and differentiation, was soon identified as a potential candidate for the progression of breast cancer, where cells are proliferating and surviving inappropriately (Clevenger et al, 2003). This evidence concerns the gene PRL and breast carcinoma.